MedSina
Health library › Evidence-based

IVF Outcomes: Long-Term Health, Migraine, Weight, and Epilepsy

September 27, 2026·6 min read ·MedSina Evidence · PubMed

As in vitro fertilization (IVF) becomes more common, ongoing research is exploring its long-term health implications for mothers and specific considerations for women with conditions like migraine, obesity, or epilepsy.

IVF Outcomes: Long-Term Health, Migraine, Weight, and Epilepsy

In vitro fertilization (IVF) has become a widely used and effective treatment for infertility, helping countless individuals and couples achieve parenthood [1]. As the use of IVF continues to grow, there is increasing interest in understanding its potential long-term effects on the health of women who undergo these treatments [1]. Beyond the immediate goal of conception, researchers are investigating how IVF might influence maternal health in the years following treatment, as well as specific considerations for women with pre-existing health conditions during their fertility journey. This article explores recent research focusing on long-term health outcomes, managing conditions like migraine and epilepsy during IVF, and the role of weight management in improving success rates.

Long-Term Maternal Health After IVF

One area of significant interest is the long-term health of mothers who conceive through IVF. A retrospective cohort study is currently assessing the association between conception via autologous IVF (using a woman's own eggs) and the long-term incidence of chronic diseases [1]. This study compares IVF mothers to two reference groups: women who conceived through medically unassisted conception (UC) and age-matched women who have not given birth (nulliparous women) [1]. Researchers used electronic health records from a large health maintenance organization, including women who delivered before age 45 between 2000 and 2018 [1]. The study aims to provide valuable insights into whether IVF conception is linked to different long-term health outcomes compared to other groups, helping to inform both patients and clinicians about potential considerations beyond pregnancy and delivery [1].

Managing Migraine During Fertility Treatment

For women who experience migraines, undergoing fertility treatments like IVF can raise questions about how hormonal changes might affect their condition. Migraine and infertility are both common among women of childbearing age, and fluctuations in estradiol (a form of estrogen) are known to influence migraines [2]. A prospective study is investigating whether women experience increased headache burden and disability during an IVF cycle, particularly those with a history of migraine [2]. The study hypothesizes that women with pre-existing migraines may experience greater headache-related disability and associated psychological symptoms during IVF, and that this disability might increase when estrogen levels peak after ovulation [2]. Researchers are also assessing psychological symptoms and estradiol levels to better understand these potential connections [2]. This research aims to help healthcare providers better support women with migraine undergoing fertility treatments.

Weight Management and IVF Success

Obesity is a known factor that can affect fertility and the success of assisted reproductive technologies (ART), including IVF. A retrospective cohort study aimed to evaluate whether a targeted weight loss intervention before ART could improve live birth rates in women with obesity and infertility (defined as a body mass index, or BMI, of 30 kg/m² or higher) [4]. The study included 308 women and compared a "Target-oriented Group" to a "Standard Lifestyle Group" [4]. The Target-oriented Group received a comprehensive weight loss intervention, including a low-calorie diet, increased physical activity, and orlistat (a medication to reduce fat absorption), with the goal of achieving an 8% weight reduction [4]. The Standard Lifestyle Group received general lifestyle advice without specific weight loss targets [4]. By comparing these approaches, the study seeks to determine if a structured weight loss program can significantly improve outcomes for obese women undergoing IVF [4].

Infertility Treatment for Women with Epilepsy

Women with epilepsy who are considering or undergoing infertility treatment face unique challenges, particularly regarding how assisted reproductive technologies (ART) might impact their seizure control. A systematic review was conducted to understand this complex interaction [5]. The review identified four studies, including case reports, a case series, and a cohort study, involving 16 women aged 25-46 years who were undergoing infertility treatment [5]. Most of these women had epilepsy and were treated with various antiseizure medications (ASMs) such as carbamazepine, clobazam, lamotrigine, levetiracetam, oxcarbazepine, valproate, and zonisamide [5]. The interventions included in vitro fertilization (IVF), ovulation induction, and other hormonal therapies [5]. The systematic review aimed to shed light on the impact of ART on seizure control in this specific patient population, providing crucial information for both patients and their healthcare teams [5].

Important Considerations for Patients

For any woman considering or undergoing fertility treatment, it is essential to have open and thorough discussions with her healthcare team. This includes sharing a complete medical history, especially regarding chronic conditions like migraine or epilepsy, and discussing any concerns about long-term health [1, 2, 5]. For those with obesity, exploring weight management strategies with a doctor before starting ART may be beneficial, as research continues to investigate its potential impact on live birth rates [4]. While current research is still exploring many of these areas, staying informed and working closely with medical professionals ensures that treatment plans are tailored to individual needs and health profiles.

Conclusion

The field of assisted reproductive technology is continuously evolving, with ongoing research dedicated to understanding not only the immediate success of treatments like IVF but also their broader implications for women's health. Studies are actively investigating long-term maternal health outcomes, the management of co-existing conditions such as migraine and epilepsy during fertility treatments, and the role of lifestyle interventions like weight loss in improving IVF success rates [1, 2, 4, 5]. These efforts underscore a commitment to providing comprehensive care and ensuring the best possible health outcomes for women pursuing parenthood through IVF.

Sources

IVFInfertilityWomen's HealthFertility TreatmentMaternal HealthMigraineObesityEpilepsy

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.